Creative Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 26-07-2024
- Paid Up Capital ₹ 0.50 M
as on 26-07-2024
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.90 M
as on 26-07-2024
- Satisfied Charges ₹ 2.00 M
as on 26-07-2024
- Revenue -0.35%
(FY 2023)
- Profit -21.64%
(FY 2023)
- Ebitda -7.85%
(FY 2023)
- Net Worth 1.07%
(FY 2023)
- Total Assets -0.26%
(FY 2023)
About Creative Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.90 M. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Shah and Rupeshkumar Shah serve as directors at the Company.
- CIN/LLPIN
U24231GJ1989PTC012151
- Company No.
012151
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Creative Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Shah  | Director | 11-Apr-2005 | Current |
| Rupeshkumar Shah | Director | 23-Jun-2021 | Current |
Financial Performance of Creative Remedies.
Creative Remedies Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.35% decrease. The company also saw a substantial fall in profitability, with a 21.64% decrease in profit. The company's net worth moved up by a moderate rise of 1.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Creative Remedies?
In 2023, Creative Remedies had a promoter holding of 59.00% and a public holding of 41.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Swami Samarth Multispeciality Hosp Ital LlpActive 3 years 29 days
Sandeep Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Cosmos Co-Operative Bank Limited Creation Date: 02 Mar 2007 | ₹2.50 M | Open |
Co-Op Bank Of Ahmedabad Ltd Creation Date: 18 Apr 1994 | ₹1.00 M | Open |
Co-Op Bank Of Ahmedabad Ltd Creation Date: 07 Mar 1992 | ₹0.40 M | Open |
How Many Employees Work at Creative Remedies?
Unlock and access historical data on people associated with Creative Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Creative Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Creative Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
